Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept

S Georgiev, D Tanase, T Genz, P Ewert… - Cardiology in the …, 2018 - cambridge.org
ObjectivesThis study aimed to develop a method for retrieval of the new meshed nitinol atrial
septal defect occluders–Ceraflex and Occlutech. BackgroundThe newly developed atrial …

Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept

S Georgiev, D Tanase, T Genz… - Cardiology in the …, 2018 - pubmed.ncbi.nlm.nih.gov
Objectives This study aimed to develop a method for retrieval of the new meshed nitinol
atrial septal defect occluders-Ceraflex and Occlutech. Background The newly developed …

Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept

S Georgiev, D Tanase, T Genz, P Ewert… - Cardiology in the …, 2018 - search.proquest.com
Objectives This study aimed to develop a method for retrieval of the new meshed nitinol
atrial septal defect occluders-Ceraflex and Occlutech. Background The newly developed …

Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept

S Georgiev, D Tanase, T Genz… - Cardiology in the …, 2018 - epub.ub.uni-muenchen.de
Objectives: This study aimed to develop a method for retrieval of the new meshed nitinol
atrial septal defect occluders-Ceraflex and Occlutech. Background: The newly developed …

Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept.

S Georgiev, D Tanase, T Genz, P Ewert… - Cardiology in the …, 2018 - europepmc.org
Objectives This study aimed to develop a method for retrieval of the new meshed nitinol
atrial septal defect occluders-Ceraflex and Occlutech. Background The newly developed …